Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cornberg

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Alimentary Pharmacology & Therapeutics|October 17, 2013
The clinical significance of drug-drug interactions in the era of direct-acting anti-viral agents against chronic hepatitis CB Maasoumy, K Port, B Calle Serrano, et al.
Alimentary Pharmacology & Therapeutics|November 12, 2013
Detection of low HCV viraemia by repeated HCV RNA testing predicts treatment failure to triple therapy with telaprevirB Maasoumy, B Cobb, B Bremer, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|June 17, 2000
Proinflammatory cytokines trigger MUC gene expression and mucin release in the intestinal cancer cell line LS180M L Enss, M Cornberg, S Wagner, et al.
Pflugers Archiv : European Journal of Physiology|November 3, 1998
Morphological and molecular characterization of human gastric mucous cells in long-term primary cultureS Wagner, M L Enss, M Cornberg, et al.
Zeitschrift Fur Gastroenterologie|August 17, 2012
[Costs of guideline-based treatment of hepatitis B patients in Germany]J T Stahmeyer, H Becker, S Heidelberger, et al.
Journal of Viral Hepatitis|February 1, 2008
Impaired TRAIL-dependent cytotoxicity of CD1c-positive dendritic cells in chronic hepatitis C virus infectionS Ciesek, H Liermann, J Hadem, et al.
Alimentary Pharmacology & Therapeutics|December 6, 2017
Interferon-free therapy of chronic hepatitis C with direct-acting antivirals does not change the short-term risk for de novo hepatocellular carcinoma in patients with liver cirrhosisF Mettke, B Schlevogt, K Deterding, et al.
The New England Journal of Medicine|January 17, 2002
Treatment of acute hepatitis C with interferon alfa-2bE Jaeckel, M Cornberg, H Wedemeyer, et al.
Infection|December 18, 2007
Clearance of chronic HCV infection during acute delta hepatitisK Deterding, S V Pothakamuri, V Schlaphoff, et al.
Journal of Viral Hepatitis|May 15, 2025
Droplet Digital PCR: A Powerful Tool for Accurate Quantification of Hepatitis D Virus RNA Levels and Verification of Detection LimitsL Sandmann, L Windzio, B Bremer, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Alimentary Pharmacology & Therapeutics|October 17, 2013
The clinical significance of drug-drug interactions in the era of direct-acting anti-viral agents against chronic hepatitis CB Maasoumy, K Port, B Calle Serrano, et al.
Alimentary Pharmacology & Therapeutics|November 12, 2013
Detection of low HCV viraemia by repeated HCV RNA testing predicts treatment failure to triple therapy with telaprevirB Maasoumy, B Cobb, B Bremer, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|June 17, 2000
Proinflammatory cytokines trigger MUC gene expression and mucin release in the intestinal cancer cell line LS180M L Enss, M Cornberg, S Wagner, et al.
Pflugers Archiv : European Journal of Physiology|November 3, 1998
Morphological and molecular characterization of human gastric mucous cells in long-term primary cultureS Wagner, M L Enss, M Cornberg, et al.
Zeitschrift Fur Gastroenterologie|August 17, 2012
[Costs of guideline-based treatment of hepatitis B patients in Germany]J T Stahmeyer, H Becker, S Heidelberger, et al.
Journal of Viral Hepatitis|February 1, 2008
Impaired TRAIL-dependent cytotoxicity of CD1c-positive dendritic cells in chronic hepatitis C virus infectionS Ciesek, H Liermann, J Hadem, et al.
Alimentary Pharmacology & Therapeutics|December 6, 2017
Interferon-free therapy of chronic hepatitis C with direct-acting antivirals does not change the short-term risk for de novo hepatocellular carcinoma in patients with liver cirrhosisF Mettke, B Schlevogt, K Deterding, et al.
The New England Journal of Medicine|January 17, 2002
Treatment of acute hepatitis C with interferon alfa-2bE Jaeckel, M Cornberg, H Wedemeyer, et al.
Infection|December 18, 2007
Clearance of chronic HCV infection during acute delta hepatitisK Deterding, S V Pothakamuri, V Schlaphoff, et al.
Journal of Viral Hepatitis|May 15, 2025
Droplet Digital PCR: A Powerful Tool for Accurate Quantification of Hepatitis D Virus RNA Levels and Verification of Detection LimitsL Sandmann, L Windzio, B Bremer, et al.
Pageof 7